Context Therapeutics Inc.

Nasdaq CNTX · Philadelphia, PA

Works in Dermatology · GI & liver · Metabolic & endocrine · Oncology · Renal & urogenital · Respiratory · Women's health

Context Therapeutics Inc. is a clinical trial sponsor based in Philadelphia, PA, listed as Nasdaq CNTX. It has 2 active clinical trials with 318 planned participants, across 7 therapeutic areas. Since 2021 it has completed 0 trials and stopped 3 early.

Trial track record · since 2021

2Active trials318 planned participants
0Completed1 with results posted
3Stopped earlyterminated, withdrawn or suspended

Financials · Nasdaq CNTX

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 2 active trials

StageTrialStatus

Questions about Context Therapeutics Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-05.

Approve Suite is not affiliated with Context Therapeutics Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.